Support & Contact
We’d love to hear from you.
Please reach out to call 1-877-375-0825 for
- General Information/Opt In
- Medical Affairs Inquiry/Adverse Event Reporting.
Alternatively, you can use the form below to select your reason for contacting us.

We are collecting this personal information in order to respond to the inquiry or request you are sending via this Contact Us form. Nobelpharma understands the importance of protecting your information and, unless you select to Opt-In, will use your information for the sole purpose of responding to your inquiry or request. Nobelpharma is a global company so a response to your inquiry may require assistance from Nobelpharma organizations in other countries. Therefore, your information may be transferred to other countries that may not have equivalent laws protecting personal information. By submitting your inquiry or request, you agree that your information will be governed by our Privacy Policy.
If you select opt in, you may be provided with online advertisements on Nobelpharma or third-party web sites that aretailored to you, for example, on the basis of nonidentifying information or of your web browsing activity. When aNobelpharma communication is delivered to you, you will see information about how to opt-out. By opting in, you agreeand understand that your information will be governed by our Privacy Policy.
Indication and Important Safety Information
Indication HYFTOR® is an mTOR inhibitor immunosuppressant indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older.
Important Safety Information
Contraindications HYFTOR® is contraindicated in patients with a history of hypersensitivity to sirolimus or any other component of HYFTOR®.